Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Novartis AG ADR

Start price
Target price
Perf. (%)
€79.40
21.09.22
€70.00
21.09.23
20.40%
22.09.23

Hugo Boss AG NA

Start price
Target price
Perf. (%)
€53.38
21.09.22
-
21.12.22
-11.75%
29.09.22

Business model of the past or high risk
Below average Marketposition
Little known brand
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€146.94
21.09.22
€120.00
21.09.23
-24.49%
19.12.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
buy
Immunocore Holdings Plc

Start price
Target price
Perf. (%)
€44.20
20.09.22
€70.00
31.12.25
22.17%
05.05.23

Could be very worthwhile Investment >20% year
Sfc Energy AG

Start price
Target price
Perf. (%)
€20.50
20.09.22
€16.00
20.09.23
-13.46%
01.10.22

Small challenges to pay loans and raise capital
Capable Management
Revenue growth >5% per year expected
EBIT growth >5% per year expected
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€9.18
20.09.22
€6.00
20.09.23
0.33%
01.10.22

Could be worthwhile Investment >10% per year
Good culture
Below average Management
Little innovation
buy
Ringmetall SE

Start price
Target price
Perf. (%)
€4.87
20.09.22
€6.00
20.09.23
-12.73%
01.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Uniper SE

Start price
Target price
Perf. (%)
€4.20
20.09.22
€1.00
20.09.23
-6.38%
01.10.22

Below average Management
Bad culture
Little innovation
Risky Investment
Altech Advanced Materials AG

Start price
Target price
Perf. (%)
€6.20
20.09.22
€4.00
20.09.23
-15.48%
01.10.22

Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Significant cyclical dependencies
Little known brand
Carbios S.A.

Start price
Target price
Perf. (%)
€25.90
20.09.22
€18.60
20.09.23
-9.81%
13.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Alibaba Health Information Technology Ltd

Start price
Target price
Perf. (%)
€0.51
20.09.22
€0.40
20.09.23
-10.61%
03.10.22

Revenue growth >5% per year expected
Low dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
20.09.22
€1.80
20.09.23
36.59%
19.11.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Inovio Pharma

Start price
Target price
Perf. (%)
€1.88
20.09.22
€1.60
20.09.23
-7.46%
03.10.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€7.75
20.09.22
€3.00
20.09.23
-52.24%
11.01.23

Revenue growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
Mercadolibre Inc

Start price
Target price
Perf. (%)
€910.20
20.09.22
€830.00
20.09.23
-6.83%
03.10.22

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
buy
International Business Machines Corp

Start price
Target price
Perf. (%)
€125.86
20.09.22
€131.00
20.09.23
10.39%
31.10.22

Could be worthwhile Investment >10% per year
High dividend yield expected
Standard Investments for future growth
Future proof or reliable business model
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.17
20.09.22
-
20.09.23
-15.38%
15.10.22

Risky Investment
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€228.00
20.09.22
€270.00
20.09.23
11.84%
21.09.23

buy
Top Dividenden Aristokraten (WF)

Start price
Target price
Perf. (%)
€164.91
20.09.22
€175.00
20.09.23
2.04%
21.09.23

buy
Visa Inc. A

Start price
Target price
Perf. (%)
€193.40
20.09.22
€239.00
20.09.23
17.24%
21.09.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Well known brand
buy
Danone S.A.

Start price
Target price
Perf. (%)
€49.80
20.09.22
€65.00
20.09.23
7.37%
21.09.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€16.65
20.09.22
€32.00
31.01.23
-17.72%
30.09.22

Could be very worthwhile Investment >20% year
buy
Tricida

Start price
Target price
Perf. (%)
€10.34
20.09.22
€25.00
30.11.23
-93.82%
24.10.22

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.18
20.09.22
€7.00
31.08.25
32.08%
05.05.23

Could be very worthwhile Investment >20% year
buy
Coeur Mining Inc.

Start price
Target price
Perf. (%)
€3.35
19.09.22
-
19.09.23
9.28%
07.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group